Ameriprise Financial Inc Sorrento Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.74 - $1.83 $2,849 - $7,047	-3,851 Reduced 3.99%	92,656 $82,000
Q3 2022 Nov 14, 2022	SELL	$1.51 - $2.88 $726 - $1,385	-481 Reduced 0.5%	96,507 $152,000
Q2 2022 Aug 15, 2022	BUY	$1.24 - $2.33 $26,532 - $49,855	21,397 Added 28.31%	96,988 $195,000
Q1 2022 May 16, 2022	SELL	$2.0 - $4.9 $8,820 - $21,609	-4,410 Reduced 5.51%	75,591 $176,000
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.23 $64,276 - $99,940	-13,823 Reduced 14.73%	80,001 $372,000
Q3 2021 Nov 15, 2021	BUY	$7.41 - $10.99 $2,689 - $3,989	363 Added 0.39%	93,824 $716,000
Q2 2021 Aug 16, 2021	BUY	$6.35 - $10.0 $75,533 - $118,950	11,895 Added 14.58%	93,461 $881,000
Q1 2021 May 17, 2021	BUY	$7.03 - $16.51 $69,491 - $163,201	9,885 Added 13.79%	81,566 $674,000
Q4 2020 Feb 12, 2021	SELL	$5.76 - $11.95 $48,384 - $100,380	-8,400 Reduced 10.49%	71,681 $489,000
Q3 2020 Nov 16, 2020	BUY	$6.17 - $18.82 $95,018 - $289,828	15,400 Added 23.81%	80,081 $893,000
Q2 2020 Aug 14, 2020	BUY	$1.73 - $6.76 $8 - $33	5 Added 0.01%	64,681 $406,000
Q1 2020 May 15, 2020	BUY	$1.57 - $4.76 $101,541 - $307,857	64,676 New	64,676 $119,000
Q3 2019 Nov 14, 2019	SELL	$2.05 - $2.69 $25,788 - $33,840	-12,580 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$2.67 - $4.38 $240 - $394	-90 Reduced 0.71%	12,580 $34,000
Q1 2019 May 15, 2019	SELL	$1.86 - $5.94 $576 - $1,841	-310 Reduced 2.39%	12,670 $60,000
Q4 2018 Feb 14, 2019	SELL	$2.01 - $4.24 $12,763 - $26,924	-6,350 Reduced 32.85%	12,980 $31,000
Q3 2018 Nov 14, 2018	SELL	$4.22 - $7.5 $844 - $1,500	-200 Reduced 1.02%	19,330 $85,000
Q2 2018 Aug 14, 2018	BUY	$4.75 - $8.0 $92,767 - $156,240	19,530 New	19,530 $141,000

Others Institutions Holding SRNE

# of Institutions

Shares Held

5.47M

Call Options Held

Put Options Held

View Full List

About Sorrento Therapeutics, Inc.

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

More about SRNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account